Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of AK112 With or Without AK117 for Patients With Metastatic Colorectal Cancer

NCT05382442 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT05382442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of AK112 With or Without AK117 for Patients With Metastatic Colorectal Cancer
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 27, 2022
Completion date
August 12, 2028
Enrollment
254 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer